Bharat Book Bureau Provides the Trending Market Research Report on “Global Recombinant Proteins Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028”under Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.
According to Our company data, the global Recombinant Proteins Market is estimated at 710 million US$ in 2021 and is expected to reach 1340 million US$ by the end of 2028, growing at a CAGR of 9.4% in the forecast period between 2022 and 2028.
This report studies the Recombinant Proteins market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Recombinant Proteins in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.
Market Snapshot, By Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.
Main Market Players Analyzed in this report, including:
Thermo Fisher Scientific
Sigma Aldrich Company
Reprocell
R&D Systems
ProSpec Tany TechnoGene
PeproTech
Miltenyi Biotec
Merck KGaA
Lonza
GenScript Biotech Corporation
GE Healthcare
Eurogentec (Kaneka Corporation)
BPS Bioscience
Abnova Corporation
Abcam PLC
The study objectives of this report are:
To study and analyze the global Recombinant Proteins market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Recombinant Proteins market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Recombinant Proteins manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Recombinant Proteins market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Recombinant Proteins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Recombinant Proteins are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Browse our full report with Table of Content : https://www.bharatbook.com/report/1297888/global-recombinant-proteins-industry-outlook-overview-opportunities-key-companies-and-forecast-to
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
Recombinant protein production requires a special technique known as recombinant DNA (rDNA) technology.Key Drivers of Global Recombinant Proteins MarketIncrease in research and development expenditure on biologics drug from major market players is a major factor driving the global recombinant proteins market.
Recombinant proteins require less clinical trial time as compared to small molecules, which helps enhance patient protection and provides pharmaceutical companies with longer exclusive sales time.Recombinant proteins are employed in the treatment of major chronic diseases such as cancer, cardiovascular diseases, endocrine diseases, and viral diseases.
Globally, about 1 in 6 deaths is due to cancer.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=80354Hormone Segment to be Highly PromisingBased on product type, the global recombinant proteins market can be segmented into hormone, growth factor, cytokines, enzymes, and othersThe hormone segment accounted for a prominent share of the global recombinant proteins market in 2019.
It is anticipated to expand significantly during the forecast period.Recombinant protein containing products are used in the treatment of diseases such as diabetes, cancer, and inflammatory diseases.
According to International Diabetes Federation, in 2019, approx.
463 million adults (20-79 years) were living with diabetes, and this value is projected to reach 700 million by 2045.Request COVID Analysis on Recombinant Proteins Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=80354 North America to Dominate Global Recombinant Proteins MarketIn terms of region, the global recombinant proteins market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & AfricaNorth America dominated the global recombinant proteins market in 2019.
